Skip to main content

Table 2 Organ absorbed doses

From: Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteers

Organ Absorbed dose (μGy/MBq)
Adrenals 4.6 ± 0.9
Brain 4.0 ± 0.3
Breasts 2.2 ± 0.0
Gallbladder wall 5.4 ± 0.4
Heart wall 12.8 ± 0.5
Kidneys 21.0 ± 0.5
Liver 8.3 ± 0.9
Lower large intestine wall 2.3 ± 0.1
Lungs 16.8 ± 2.7
Muscle 2.2 ± 0.1
Osteogenic cells 3.6 ± 0.1
Ovaries 2.5 ± 0.1
Pancreas 16.5 ± 2.2
Red marrow 3.2 ± 0.1
Skin 1.7 ± 0.1
Small intestine 5.4 ± 0.9
Spleen 16.6 ± 6.6
Stomach wall 4.5 ± 0.9
Testes 3.6 ± 0.7
Thymus 2.1 ± 0.0
Thyroid 12.0 ± 3.9
Upper large intestine wall 2.8 ± 0.1
Urinary bladder wall 2.1 ± 0.1
Uterus 2.5 ± 0.1
Total body 2.8 ± 0.0
Effective dose (μSv/MBq) 5.9 ± 0.6
  1. Data are the mean ± SD for healthy male subjects (n = 3)